Wednesday, February 20, 2019

Job posting: principal investigator, Nephron Technologies, Minneapolis, MN

From the inbox, a position with a new startup in Minneapolis, MN:
Job Title: Principal Investigator
Company Name: Nephron Technologies
Location: Minneapolis, MN 
Education Requirement: PhD or MS in Chemistry or Chemical Engineering or related field. 
Skills: Analytical chemistry, Chemical/Process Engineering, Electrical/Computer Engineering, Prototyping, Systems Analysis, Controls, Computer Programming, Mass Transport. 
Job Description: Nephron Technologies is a seed-stage startup company focused on revolutionizing dialysis technology. We are searching for a Principal Investigator to lead our proof-of-concept operations, contingent on award of an NIH SBIR Phase I grant. The term of employment begins as soon as the grant is awarded. If we are successful with the Phase I grant, which covers six months of work, we will apply for a Phase II grant, which covers an additional year of work. We will then seek other sources of funding to continue our efforts. 
Because this is a startup company, we cannot guarantee that this will be a stable source of employment. We can only employ you if we are successful with grants. Compensation will include equity in the company in addition to a salary. 
Your work will include designing and testing a benchtop dialysis device. We will collect data, write reports, and plan experiments. There may be an opportunity for publications. Because you will be a technical leader on the project, there is an opportunity to become an executive officer depending on how long you want to stay! 
Please email me only if you meet the requirements above, and you are seeking a fast-paced, high-risk, high-reward position like this. Unfortunately, we cannot support relocation. 
Contact Information:
Best wishes to those interested.  

No comments:

Post a Comment

looks like Blogger doesn't work with anonymous comments from Chrome browsers at the moment - works in Microsoft Edge, or from Chrome with a Blogger account - sorry! CJ 3/21/20